The US is the bigger Apheresis Equipments market: $1.1 Bn against $46 Mn in 2023, about 23 times as large.
India grows faster: 9.2% a year, against 4.2%. The gap still grows from $1 Bn to $1.5 Bn by 2033.
Clinical research: 235 active trials in the US, 7 in India.
| Measure |  US |  India |
|---|---|---|
| Market size, 2023 | $1.1 Bn | $46 Mn |
| Market size, 2033 projected | $1.6 Bn | $111 Mn |
| Growth a year (CAGR) | 4.2% | 9.2% |
| Money added, 2023–2033 | $543 Mn | $65 Mn |
| Share of the world market | 42% | 1.8% |
| Size rank of 24 countries | #1 | #12 |
| Market per person, 2023 | $3.12 | $0.03 |
| Active clinical trials | 235 | 7 |
| Full report | US report | India report |
Year by year, 2023 to 2033
US India · values between 2023 and 2033 are projected from the 2023 size and the CAGR.
Quick answers
Which is bigger in Apheresis Equipments, US or India?
The US is the bigger Apheresis Equipments market: $1.1 Bn against $46 Mn in 2023, about 23 times as large.
Which grows faster in Apheresis Equipments, US or India?
India grows faster: 9.2% a year, against 4.2%. The gap still grows from $1 Bn to $1.5 Bn by 2033.
More Apheresis Equipments comparisons
Sources: market size and growth: Acuitas Health Analytics research (2023 base year, forecasts to 2033). Trials: ClinicalTrials.gov (fetched 10 Nov 2026); found by search words, so counts are a guide. Population: World Bank.